Peyronie's disease: An anatomically-based hypothesis and beyond

International Journal of Impotence Research

Volumn 14, Issue 5, 2002, Pages 411-413

  Lue, T F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fibrosis; Peyronie's disease; Transforming growth factor beta (TGF beta)

Indexed keywords

ANTIFIBROTIC AGENT; COLCHICINE; COLLAGENASE; CONNECTIVE TISSUE GROWTH FACTOR; METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; VERAPAMIL;

ARTERIAL CIRCULATION; COLLAGEN DEGRADATION; ELASTIC FIBER; FUNCTIONAL ANATOMY; HISTOPATHOLOGY; HUMAN; LEUKOCYTE MIGRATION; MACROPHAGE MIGRATION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PEYRONIE DISEASE; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT PLANNING; TUNICA ALBUGINEA;

ANIMALS; FIBROSIS; HUMANS; MALE; MODELS, BIOLOGICAL; PENILE INDURATION; RESEARCH; TRANSFORMING GROWTH FACTOR BETA;

EID: 0036805142     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900876     Document Type: Short Survey

References (14)

1. Border WA, Ruoslahti E. Transforming growth factor-β in disease: The dark side of tissue repair. J Clin Invest 1992; 90: 1-7.
2. EI-Sakka AI et al. An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. J Urol 1997; 158: 2284-2290.
3. Bivalacqua TJ et al. Evaluation of nitric oxide synthase and arginase in the induction of a Peyronie's-like condition in the rat. J Androl 2001; 22: 497-506.
4. Nyberg LM Jr, Bias WB, Hochberg MC, Walsh PC. Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens. J Urol 1982; 128: 48-51.
5. Noss MB, Day NS, Christ GJ, Melman A. The genetics and immunology of Peyronie's disease. Int J Impot Res 2000; 12: S127-S132.
6. Falke G. Caffaratti J, Atala A. Tissue engineering of the bladder. World J Urol 2000; 18: 36-43.
7. Sievert KD et al. Heterologous acellular matrix graft for reconstruction of the rabbit urethra: Histological and functional evaluation. J Urol 2001; 165(6 Pt 1): 2096-2102.
8. el-Sakka AI et al. The effects of colchicine on a Peyronie's-like condition in an animal model. J Urol 1999; 161: 1980-1983.
9. Tefekli A et al. The effect of decorin on the rat model of Peyronie's disease. J Urol 2001; 165: 200.
10. Anderson MS, Shankey TV, Lubrano T, Mulhall JP. Inhibition of Peyronie's plaque fibroblast proliferation by biologic agents. Int J Impot Res 2000; 12: S25-S31.
11. Rogers RS et al. Intracavernosal VEGF and AAV-VEGF gene prevents ED in a rat model of venous leakage impotence. J Urol 2001; 165: 221.
12. Levine LA. Treatment of Peyronie's disease with intralesional verapamil injection. J Urol 1997; 158: 1395-1399.
13. Gelbard MK, James N, Riach P, Dorey F. Collagenase versus placebo in the treatment of Peyronie's diseas: A double blind study. J Urol 1993, 149: 56-58.
14. Schwarzer U et al. Prevalence of Peyronie's disease: Results of an 8000 men survey. J Urol 2000; 163: 167.